While previous research has shown that the COVID-19 vaccine is safe for pregnant women, a new study by UK researchers finds that maternal vaccinations are an effective way to protect both mom AND baby until the baby becomes eligible for the vaccine.
A team of faculty and students have developed the face mask membrane that can capture and deactivate the SARS-CoV-2 spike protein on contact. The innovation is another layer of protection against COVID-19 that can help prevent the virus from spreading.
According to a new University of Kentucky College of Medicine study, asymptomatic COVID-19 infection during pregnancy could still have potential long-term consequences for a developing baby.
UK College of Medicine researcher Ilhem Messaoudi, Ph.D., has dedicated her career to developing a better understanding of how the immune system works, paving the way for improving how people respond to vaccines and infections.
Ilhem Messaoudi, Ph.D., chair of the University of Kentucky College of Medicine’s Department of Microbiology, Immunology, and Molecular Genetics, answers questions on the latest on SARS-CoV-2 and what we might expect in the future.
Since the early days of the pandemic, a group of UK faculty members have been collecting wastewater samples to test for COVID-19. They are now taking their work on the road in a white Ford van outfitted as a mobile wastewater testing facility.
Through the College of Medicine’s Alliance Program, UK formed the Kentucky Research Alliance for Lung Disease (K-RALD). Jamie Sturgill shares how K-RALD has created a biobank allowing researchers to ask and answer critical research questions.
College of Medicine and College of Engineering researchers will be using a mobile lab to test wastewater in rural Kentucky for the presence of COVID-19.
